Please find attached Unaudited Financial Results (Consolidated and Standalone) for quarter and half year ended on September 30, 2026

~ GALAXY Chemistry Creates Care November 04, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Dalal Street, Mumbai- 400001 Mumbai – 400 051 Scrip Code: 540935 Scrip Symbol: GALAXYSURF Sub: Outcome of the Board Meeting. Ref: Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, In continuation to our intimation dated October 28, 2026, the meeting of the Board of Directors of the Company was held as scheduled today i.e. November 04, 2026 and the Board inter-alia has: Financial Results 1. Considered and approved the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter & half year ended September 30, 2026. 2. Adopted Limited Review Report on Unaudited Financial Results obtained from Statutory Auditors of the Company. Copies of the above documents attached. Interim Dividend Approved and declared Interim Dividend of Rs.18/- per equity share having face value of Rs. 10/- each, on the equity share capital of the Company for the financial year 2026-27. The Record date for payment of this interim dividend is fixed as November 11, 2026. The Dividend shall be paid within 30 days from the date of its declaration to the shareholders whose name appears in the Register of Members as on the Record date. Re-appointment of Managing Director Based on the recommendation of the Nomination and Remuneration Committee, considered and approved the re-appointment of Mr. K. Natarajan (DIN: 07626680) as a Managing Director of the Company from February 18, 2027 to March 31, 2029 subject to the approval of members. The details of Mr. K. Natarajan pursuant to SEBI circular are enclosed as Annexure ‘A’. We confirm that Mr. K. Natarajan is not debarred from holding the office of Director, by virtue of any SEBI order or any other such authority. Change in Company Secretary and Compliance Officer Mr. Niranjan Ketkar has tendered his resignation as Company Secretary and Compliance officer w.e.f. December 04, 2026. (closing hours) Based on recommendation of the Nomination and Remuneration Committee, approved the appointment of Ms. Roopali Vikram Kamate (M.No: A19814) as Company Secretary and Compliance Officer and designated her as a Key Managerial Person (“KMP”) of the Company w.e.f. December 05, 2026. The details of Ms. Roopali Vikram Kamate pursuant to SEBI circular are enclosed as Annexure ‘A’. Galaxy Surfactants Ltd. Regd. Office: C-49/2, TTC Industrial Area, Pawne, Navi Mumbai 400 703 P +91-22-39135500 F +91-39135554 E galaxy@galaxysurfactants.com www.galaxysurfactants.com CIN No. L39877MH1986PLC039877 ~ GALAXY Chemistry Creates Care Appointment of Statutory Auditors Based on the recommendation of the Audit Committee, approved the appointment of M/s. S R B C & CO LLP, Chartered Accountants, ICAI Firm Registration No. 324982E/E300003 as the Statutory Auditors of the Company for a term of five years, commencing from the conclusion of the 41st Annual General Meeting until the conclusion of the 46th Annual General Meeting, subject to approval of the Members. The details pursuant to SEBI circular are enclosed as Annexure ‘A’. The same information will be made available on the Company’s website www.galaxysurfactants.com. The meeting of the board started at 09:30 a.m. and concluded at 08:00 p.m. This is for your information and records. Yours faithfully, For Galaxy Surfactants Limited Niranjan Ketkar Company Secretary encl: as above Galaxy Surfactants Ltd. Regd. Office: C-49/2, TTC Industrial Area, Pawne, Navi Mumbai 400 703 P +91-22-39135500 F +91-39135554 E galaxy@galaxysurfactants.com www.galaxysurfactants.com CIN No. L39877MH1986PLC039877 Deloitte Chartered Accountants One International Center, Haskins & Sells LLP Tower 3, 31st Floor, Senapati Bapat Marg Elphinstone Road (West) Mumbai -400 013 Maharashtra, India Tel: +91 22 6185 6000 Fax:+912261854101 INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM CONSOLIDATED FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF GALAXY SURFACTANTS LIMITED 1. We have reviewed the accompanying Statement of Unaudited Consolidated Financial Results of Galaxy Surfactants Limited ("the Parent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group"), for the quarter and half-year ended 30th September, 2026 ("the Statement") being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("the Listing Regulations"), 2. This Statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of Parent's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. 4. The Statement includes the financial information of the following entities: Parent: Galaxy Surfactants Limited List of Subsidiaries: 1) Galaxy Chemicals (Egypt) S.A.E. 2) Galaxy Surfactants Americas Inc. 3) Galaxy Holdings (Mauritius) Limited 4) Rainbow Holdings GmbH 5) Tri-K Industries, Inc. 6) Galaxy Specialties Europe B.V. 7) Galaxy Surfactants Mexico S.A. de C.V. 8) Tri-K Mexico S.A. de C.V. Regd. Office: One International Center, Tower 3, 31st floor, Senapati Ba pat Marg, Elphinstone Road (West), Mumbai-400 013, Maharashtra, India. Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identification No: AAB-8737 Deloitte Haskins & Sells LLP 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review report of the other auditor referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We did not review the interim financial information of one subsidiary included in the unaudited consolidated financial results, whose interim financial information reflect total assets of Rs. 982. 79 crore as at 30th September, 2026, total revenues o [Showing first 8,000 characters — download PDF for full document]